Italy city Milan vaccine symptoms infection Italy city Milan

Two or 3 vaccine doses may cut risk of long COVID

Reading now: 394
www.cidrap.umn.edu

An observational study of Italian healthcare workers infected with SARS-CoV-2 who didn't require hospitalization suggests a link between two or three doses of vaccine and a lower prevalence of long COVID.In the modeling study, published late last week in JAMA, researchers in Milan studied 2,560 workers at nine healthcare facilities from March 2020 to April 2022.

All healthcare workers were mandated to receive three doses of the Pfizer/BioNTech mRNA COVID-19 vaccine in 2021. And all were screened for COVID-19 once a week or every 2 weeks and when they developed symptoms or were exposed to the virus.Participants completed a survey from February to April 2022 about their demographic factors, underlying conditions, and COVID-19–related symptoms during and after their infection.

Long COVID was defined as the presence of at least one symptom for more than 4 weeks.Odds of long COVID fell to 16% after third doseOf the 2,560 workers, 739 (29%) tested positive for COVID-19, 89 of whom had no symptoms and 229 (31%) of whom had long COVID.Long COVID prevalence changed over the course of the pandemic, from 48.1% in the first wave (February to September 2020) with the wild-type virus, to 35.9% in the second surge (October 2020 to July 2021) amid the Alpha variant, and 16.5% in the third wave (August 2021 to March 2022) with Delta and Omicron.The number of vaccine doses was linked to lower prevalence of long COVID, at 41.8% of a reference group of unvaccinated participants, 30.0% after one dose, 17.4% after two doses, and 16.0% after the third dose.

Risk factors for long COVID included older age, high body mass index, allergies, and obstructive lung disease.Compared with a reference group of unvaccinated women with no allergies or

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Waterloo Region expecting first doses of pediatric COVID-19 vaccine by end of July - globalnews.ca - Canada - county Ontario
globalnews.ca
90%
964
Waterloo Region expecting first doses of pediatric COVID-19 vaccine by end of July
Waterloo Public Health is expecting to get its first doses of Moderna’s two-dose pediatric COVID-19 vaccine for children aged six months to five years of age by the end of the month.“At this time, we are awaiting more direction from the Province,” a spokesperson told Global News in an email.“We expect to receive shipments of the Moderna vaccine towards the end of July for this age group.” COVID outbreaks more than doubled in Ontario LTC homes since last weekly report On Thursday, Health Canada announced that Moderna’s two-dose pediatric vaccine for young children had given the green light.The region says it expected approval to arrive at some point and had been planning for the rollout of the vaccine for the only remaining age group not yet offered COVID immunizations.“Pharmacies will continue to administer vaccines, and given the age of the youngest children, primary care providers will have an important role,” the spokesperson said.Earlier this week, the province announced that most people over the age of 18 would now be eligible for a fourth dose of COVID-19. Ontario to receive pediatric COVID-19 vaccine next week Within hours, the region announced that area residents would be able to get doses at family doctors, pharmacies and its clinics.Those using the region’s clinics would need to use the province’s booking system, which is the first time this would be the case.
DMCA